Skip to main content
Biohit Oyj logo

Biohit Oyj — Investor Relations & Filings

Ticker · BIOBV ISIN · FI0009005482 LEI · 74370089ATTSNBXJVT29 HE Manufacturing
Open in API
Filings indexed 992 across all filing types
Latest filing 2025-03-19 Annual Report
Country FI Finland
Listing HE BIOBV

About Biohit Oyj

https://www.biohithealthcare.com/en/

Biohit Oyj is a global biotechnology company that develops, manufactures, and markets innovative diagnostic products and services. The company specializes in tools for the early diagnosis and prevention of diseases, with a primary focus on gastroenterology. Its key offerings include the GastroPanel® blood test for assessing stomach health and screening for risks of gastric cancer, as well as diagnostic tests for conditions such as Helicobacter pylori infection. Operating under the mission "Innovating for Health," Biohit's products are designed to support medical research, facilitate early and accurate diagnosis, and improve patient quality of life.

Recent filings

Filing Released Lang Actions
Publication of Biohit Oyj Annual Re..
Annual Report Classification · 100% confidence The document is titled 'Biohit Oyj Annual Report 2024' and contains sections typical of an annual report such as CEO's review, strategy, corporate governance, financial statements, and detailed financial data for the year 2024. It includes comprehensive financial performance metrics, business strategy, product information, and governance statements. The length is substantial (15,000 characters) and it contains actual financial data and analysis, not just an announcement or summary. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2024
2025-03-19 English
Publication of Biohit Oyj Annual Re..
Annual Report Classification · 100% confidence The document is titled 'Annual Report 2024' and contains comprehensive sections including a CEO's review, strategy, product information, and detailed financial statements (including revenue, EBITDA, and profit/loss figures for 2024 vs 2023). It is a full-length report rather than an announcement or summary, fitting the definition of an Annual Report (10-K). FY 2024
2025-03-19 English
Publication of Biohit Oyj Remunerat..
Remuneration Information Classification · 98% confidence The document is titled "Palkitsemisraportti 2024" (Remuneration Report 2024) in Finnish. It details the compensation structures, fees, and stock options granted to the Board of Directors and the CEO, comparing figures across multiple years (2020-2024). It explicitly mentions compliance with the Finnish Corporate Governance Code regarding remuneration. This content directly aligns with the definition of a Remuneration Information report, which corresponds to the DEF 14A code in the provided schema, even though the document is in Finnish and the code is derived from a US filing context (Proxy Statement/Information Statement detailing executive compensation). Given the specific focus on executive and board compensation, DEF 14A is the most appropriate classification among the choices.
2025-03-19 Finnish
Publication of Biohit Oyj Remunerat..
Remuneration Information Classification · 98% confidence The document is explicitly titled '# **Remuneration report 2024**' and details the compensation structure, fees, bonuses, and share-based incentives for the Board of Directors and the CEO, referencing compliance with the Finnish Corporate Governance Code 2020. This content directly aligns with the definition of a Remuneration Information report, which corresponds to the DEF 14A code in the provided schema, even though DEF 14A is typically a US SEC filing name (Proxy Statement detailing compensation). Given the specific content focus on executive and director remuneration, DEF 14A is the most appropriate classification among the choices, overriding the general Governance Information (CGR) or Audit Report (AR). The document is a full report, not just an announcement of one.
2025-03-19 English
Biohit Oyj - Managers' Transactions
Director's Dealing Classification · 100% confidence The document text is titled 'Biohit Oyj - Johtohenkilöiden liiketoimet' (Biohit Oyj - Management Transactions) and details specific share transactions ('LUOVUTUS' - Disposal) made by an individual named Panu Hendolin, who holds the position of 'Muu ylin johto' (Other senior management). This content directly corresponds to the definition of Director's Dealing, which reports personal share transactions by company directors and executives (insider trades). The corresponding code is DIRS.
2025-03-13 Finnish
Biohit Oyj - Managers' Transactions
Director's Dealing Classification · 100% confidence The document explicitly states 'Biohit Oyj - Managers' Transactions' and details transactions (DISPOSAL) made by a 'Person subject to the notification requirement' named Panu Hendolin, who holds the 'Position: Other senior manager'. This content directly corresponds to the definition of Director's Dealing, which reports personal share transactions by company directors and executives (insider trades). The corresponding code is DIRS.
2025-03-13 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.